Evaluate Relative Bioavailability of PA32540 (Asa/Omeprazole), Its Aspirin Component, and Ecotrin® in Healthy Volunteers

Phase 1CompletedNCT00632086

POZEN36 enrolled

Overview

Study to determine a single dose bioavailablity of PA32540 is similar to EC aspirin 325 mg with respect to salicylic acid.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Masking

NONE

Enrollment

The 325 mg aspirin component of PA32540

325 mg Ecotrin

Sex: ALLMin age: 18 YearsMax age: 55 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Standard for PK * Ages 18-55 years old * Males and females Exclusion Criteria: * Standard for PK

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.